IP Library Granted Patent US 10,874,600
Granted Patent B2
US 10,874,600 · App. 16/010,944 · Granted Dec 29, 2020

Method for degrading bilirubin in skin

Inventors: Tomohiro Hakozaki (Cincinnati, OH); Bin Fang Deyer (Loveland, OH)
Assignee: The Procter & Gamble Company
A61K8/675A61Q19/00A61K2800/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,874,600
App. No.
16/010,944
Granted
Dec 29, 2020
Kind
B2
Abstract

A method of degrading bilirubin in skin is provided. The method involves identifying a target portion of skin where a reduction in bilirubin level is desired, and applying a vitamin B 3 -containing, low-pH composition to the target portion of skin during a treatment period. The composition contains an effective amount of a vitamin B 3 compound, has a pH of less than 5.0, and reduces bilirubin level in the target portion of skin during the treatment period. The amount of vitamin B 3 compound and the pH of the composition may be selected to provide a synergistic reduction in bilirubin level, as compared to the reduction in bilirubin level provided by the same composition at a neutral pH.

Claims (20)

1. A method of degrading bilirubin in skin, comprising:

a) identifying a target portion of skin on a person in need of treatment; and

b) applying a low-pH composition to the target portion of skin during a treatment period, wherein the low-pH composition comprises an effective amount of niacinamide, has a pH between 2 and 5, and reduces bilirubin level in the target portion of skin during the treatment period.

2. The method of claim 1 , wherein the pH of the composition is 4.0 or less and the composition comprises about 0.01% to about 10% of niacinamide.

3. The method of claim 1 , wherein the composition reduces bilirubin level by at least 10% during the treatment period.

4. The method of claim 1 , wherein the effective amount of niacinamide and the pH of the composition are selected to provide a synergistic reduction in bilirubin level relative to the same composition at a neutral pH.

5. The method of claim 4 , wherein the synergistic reduction in bilirubin level is at least 10% more than a predicted additive amount of bilirubin reduction.

6. The method of claim 1 , further comprising at least one additional skin care active selected from the group consisting of vitamins, minerals, peptides, sugar amines, sunscreens, oil control agents, flavonoid compounds, anti-oxidants, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents, moisturizing agents, exfoliating agents, skin lightening agents, anti-acne agents, anti-wrinkle agents, phytosterols, N-acyl amino acid compounds, antimicrobials, antifungals, and combinations thereof.

7. The method of claim 1 , further comprising about 0.1% to about 10% of a stable fatty alcohol thickener.

8. The method of claim 1 , wherein the target portion of skin in need of treatment exhibits a sign of jaundice or bruising.

9. A method of improving the appearance of sallow-looking skin, comprising:

a. determining a bilirubin level for a target portion of skin; and

b. applying a skin care composition to the target portion of skin during a treatment period when the bilirubin level exceeds a predetermined threshold value, wherein the skin composition comprises an effective amount of niacinamide, has a pH between 2 and 5, and reduces bilirubin level in the target portion of skin during the treatment period.

10. The method of claim 9 , wherein the composition provides a reduction in b* value of at least 5% relative to a predetermined b* value.

11. The method of claim 9 , wherein the cosmetic composition includes about 0.01% to about 15% niacinamide.

12. The method of claim 9 , wherein the pH is between about 2.5 and 5.0.

13. The method of claim 9 , further comprising about 0.1% to about 10% of a stable fatty alcohol thickener.

14. The method of claim 9 , further comprising at least one additional skin care active.

15. The method of claim 9 , wherein the composition reduces the bilirubin level below the threshold level.

16. The method of claim 9 , wherein the composition reduces the bilirubin level by at least 10%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2018
From: HAKOZAKI, TOMOHIRO NMN; FANG DEYER, BIN NMN
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 046141/0978 →
Continuity (1)
Related Publication 20190380945A1 · Dec 19, 2019
Cited By (1)
US 12,599,548